The land of Africa is the second largest continent in the world in both square mileage and population. Thus, it also has widespread disease and in turn, is a huge testing bed for new medications and procedures. This week Merck and Qiagen NV have announced collaboration in Rwanda to battle cervical cancer. Rwanda will be […]
Gardasil debate renewed
By Aaron Derfel, Gazette Health Reporter Critics doubt benefits for women up to age 45. MONTREAL – Health Canada’s decision to approve the Gardasil vaccine for women up to the age of 45 has renewed the debate about the purported benefits of the shots and whether they might even be necessary. Kirkland-based Merck, maker of […]
Merck, Qiagen Begin Rwandan Cervical-Cancer Program, Times Says
By Heather Murdock Merck & Co. and Qiagen NV (QGEN) will fund a program in Rwanda to screen and vaccinate women against cervical cancer, the New Times reported, citing Agnes Binagwaho, permanent secretary in the Health Ministry. Merck will provide more than 2 million doses of its Gardasil vaccine to the government at no charge, […]
HEALTH CANADA APPROVES GARDASIL® FOR WOMEN UP TO AGE 45
KIRKLAND, QC, April 26 /CNW Telbec/ – Today, Merck announced that Health Canada has extended the indication of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Recombinant Vaccine] in women up to the age of 45. Merck’s HPV vaccine is now approved for girls and women nine through 45 years of age for […]
Gardasil – The Grim Reaper – Mounting Injuries Last as Long as Vaccine Efficacy
By Leslie Carol Botha April 25, 2011 PR Log FOR IMMEDIATE RELEASE PRLog (Press Release) – Apr 25, 2011 – It is becoming hard to comprehend why the United States government; FDA, CDC and the NCI have blatantly turned their backs on the thousands of families whose daughters and sons […]
- « Previous Page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- …
- 240
- Next Page »